DOGE-ing US FDA: Three Scenarios For What Comes Next

 
• By Michael McCaughan and Ramsey Baghdadi

The US FDA has navigated one round of layoff notices, but more cuts could be coming. Here are three potential scenarios.

One scenario for FDA restructuring could be combining the drug and biologics centers. (Shutterstock)

More from US FDA

More from Pathways & Standards